Travere Therapeutics, Inc. (TVTX)
28.04
+0.23
(+0.83%)
USD |
NASDAQ |
Mar 16, 16:00
28.04
0.00 (0.00%)
After-Hours: 17:30
Travere Therapeutics Shareholders Equity (Quarterly) : 114.83M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 1.631B |
| ICU Medical, Inc. | 2.124B |
| Tandem Diabetes Care, Inc. | 155.17M |
| iRhythm Holdings, Inc. | 152.75M |
| Eli Lilly & Co. | 26.54B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 605.19M |
| Total Liabilities (Quarterly) | 490.36M |
| Debt to Equity Ratio | 2.863 |
| Current Ratio | 2.736 |
| Net Debt Paydown Yield | 0.42% |